Lloyd Price

OCTOBER 8, 2018

Machine learning is making the drug discovery process cheaper, faster, and more optimal for all involved AI is omnipresent and it’s no shock that it’s even crept its way into the highly regulated pharmaceutical industry, one that is usually risk averse and slow to adapt new technologies. What are the use cases within pharma for AI?With

Pharmaceuticals 149

Pharmaceuticals HIPAA Digital Health 149

Digital Health Global

SEPTEMBER 11, 2023

Global competitiveness and key competitor percentage market shares Market presence across multiple geographies – Strong/Active/Niche/Trivial MARKET OVERVIEW Impact of Covid-19 and a Looming Global Recession Year 2021 in Review and Near Term Outlook World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2023 COVID-19 Broadens (..)

Digital Health 88

Digital Health Telemedicine Pharmaceuticals Mobile Health 88

Health Populi

OCTOBER 24, 2022

That’s a summary of the demand side of the trends on the health economy which serve up huge challenges for legacy health care stakeholders: hospitals and health systems, health plans, pharmaceutical and medical tech companies, and clinicians.

Pharmaceuticals 130

Pharmaceuticals Primary Care Mental health Public Health 130

Lloyd Price

FEBRUARY 18, 2024

2014: Liraglutide becomes the first GLP-1 RA approved for weight management. Drug development: Pharmaceutical companies like Novo Nordisk, Eli Lilly, and AstraZeneca led the development and commercialization of GLP-1 RAs. 1996: Studies suggest GLP-1's potential in managing type 2 diabetes and obesity.

Pharmaceuticals 60

Pharmaceuticals healthcare technology Leadership Drug Development 60

Insulin Nation

OCTOBER 12, 2017

A combo treatment of metformin and canagliflozin was more effective for blood sugar control than either of the drugs individually, according to a recent study conducted by the research arm of drugmaker Janssen Pharmaceuticals. In 2014, Janssen Pharmaceuticals received FDA approval for INVOKAMET, a combo therapy of the two drugs.

Pharmaceuticals 40

Pharmaceuticals 40

Health Populi

JANUARY 27, 2022

People would be more willing to share their information with a university hospital than with a pharmaceutical or digital technology company. Differences by disease were small except people appear to be less willing to share information related to depression and diabetes versus cancer, and more willing to share information about COVID-19. .”

HIPAA 182

HIPAA Health Information EHR Pharmaceuticals 182

Medical Mime - EHR

FEBRUARY 4, 2019

In comparison to the opioid crisis, … pharmaceutical companies offered free samples and savings coupons to doctors, who then prescribed to patients who often were not made fully aware of the addictive nature of the substances they were consuming. from 2014 to 2017.

Pharmaceuticals 40

Pharmaceuticals EHR 40

Docnotes

JANUARY 27, 2020

We had a small team that worked closely with pharmaceutical companies and generated revenue from these relationships. I wasn’t very involved with this team, but due to my ownership of many of the clinical decision support initiatives, I started getting invited to meetings we had with pharmaceutical companies. Could they resist?

Pharmaceuticals 40

Pharmaceuticals EHR Life Science Pain management 40

Insulin Nation

OCTOBER 14, 2015

In the report, representatives of the pharmaceutical industry pushed back against the study, saying that the market price for a drug is often not the one paid by the consumer, as many insurers demand a deep discount. critics of the pharmaceutical industry contend that U.S. are cheaper, generic versions of name-brand drugs.

Pharmaceuticals 86

Pharmaceuticals 86

Lloyd Price

DECEMBER 8, 2018

Craig Venter in 2014—at around $310 million, according to a Human Longevity regulatory filing obtained by Lagniappe Labs LLC, whose Prime Unicorn Index tracks valuations of privately held companies. and pharmaceutical entrepreneur Robert Duggan. The funding round values the company—co-founded by genomics pioneer J.

Pharmaceuticals 56

Pharmaceuticals Life Science BioTech Drug Development 56

Health Populi

JANUARY 5, 2021

When he led Turing Pharmaceuticals in 2015, he acquired a license for the drug Daraprim (an anti-malarial therapy also used for HIV/AIDS), raising the drug price from $13.50 A quick sidebar for context: The Awards are named for Martin Shkreli, the so-called “Pharma Bro” who managed hedge funds and pharma companies.

Public Health 156

Public Health Pharmaceuticals Leadership Life Science 156

Lloyd Price

JULY 13, 2018

Japan, one of the most advanced, high-tech countries in the world, is the third-biggest pharmaceuticals market, behind only the USA and China, and it is larger than France and Germany’s pharma sectors combined. Source : [link]

Pharmaceuticals 40

Pharmaceuticals Life Science 40

Healthcare IT Today

APRIL 21, 2023

Series B funding proceeds will enable Scene to further accelerate its ability to serve Medicaid and Medicare managed care plans, pharmaceutical companies, and clinical research organizations. This financing brings the total investment in Scene to over $25 million since its founding in 2014.

Life Science 57

Life Science Medicare Public Health Nursing 57

Insulin Nation

OCTOBER 14, 2015

In the report, representatives of the pharmaceutical industry pushed back against the study, saying that the market price for a drug is often not the one paid by the consumer, as many insurers demand a deep discount. critics of the pharmaceutical industry contend that U.S. are cheaper, generic versions of name-brand drugs.

Pharmaceuticals 60

Pharmaceuticals 60

Lloyd Price

NOVEMBER 2, 2018

In October 2018, pharmaceutical giant Pfizer and private-equity firm Bain Capital LP announced the formation of Cerevel Therapeutics LLC, a drug-discovery collaboration for central nervous system disorders. The DDF was founded in 2014 and has backers that include the AARP, the NFL Players Association, U.K.

BioTech 40

BioTech Pharmaceuticals 40

Lloyd Price

APRIL 17, 2023

Billion valuation and loss of a development deal with Otsuka Pharmaceuticals. Partnership and collaboration: Healthcare providers, pharmaceutical companies, and technology companies are likely to form more partnerships and collaborations to develop and commercialize DTx solutions.

Digital Health 97

Digital Health Pharmaceuticals Mental health Telemedicine 97

Insulin Nation

JANUARY 23, 2015

Continuous glucose monitor maker Dexcom finished up a fantastic fiscal year in 2014, with revenues up by 64% compared to the previous year. According to a Fierce Medical Devices report, shareholders from both Medtronic and Covidien have approved the merger of the two pharmaceutical companies, both of which make insulin pumps.

Pharmaceuticals 70

Pharmaceuticals 70

Medical Mime - EHR

APRIL 11, 2018

Findings from the MicroStrategy article: (1) Pharmaceutical payments to doctors do not affect prescription rates. We were curious whether the data would show a correlation between pharmaceutical company payments to doctors and their rates of prescription. MicroStrategy – source article , interactive dashboard.

Pharmaceuticals 40

Pharmaceuticals EHR 40

Insulin Nation

OCTOBER 14, 2015

In the report, representatives of the pharmaceutical industry pushed back against the study, saying that the market price for a drug is often not the one paid by the consumer, as many insurers demand a deep discount. critics of the pharmaceutical industry contend that U.S. are cheaper, generic versions of name-brand drugs.

Pharmaceuticals 40

Pharmaceuticals 40

ACA Times

JANUARY 13, 2016

Despite criticism from patients, insurers and lawmakers, pharmaceutical companies have continued to increase the cost of drugs, with many hiking prices by 10% or more just before or after the New Year. in 2014, compared to just 2.4% Spending on prescription drugs rose by 12.2% the prior year, Loftus reports. Pfizer Inc.

Pharmaceuticals 40

Pharmaceuticals Medicare 40

Insulin Nation

MAY 18, 2014

Glucagon quickly degrades with water, so it usually is kept in powder form and must be quickly mixed with water during an emergency, says Doug Baum, CEO of Xeris Pharmaceuticals. It’s an invaluable tool to help people with diabetes, but not a convenient one. Glucagon is a poster child of a drug that does not do well with water,” says Baum.

Pharmaceuticals 97

Pharmaceuticals 97

Health Populi

MARCH 22, 2022

Health Populi’s Hot Points: The concept of financial toxicity was raised in a 2014 60 Minutes segment during which correspondent Lesley Stahl spoke with Dr. Leonard Saltz of Memorial Sloan Kettering Medical Center in New York City. Dr. Saltz was speaking as chief of the department of gastrointestinal oncology.

Medical Billing 170

Medical Billing Pharmaceuticals Health Policy 170

Society for Participatory Medicine

JANUARY 27, 2022

Healthcare stakeholders such as health systems, pharmaceutical companies, biotech and life sciences firms, and insurance companies serve patients as end users. My mission of advocacy was widened and deepened upon my stage IV colorectal cancer diagnosis in 2014 when I shared my expertise with others fighting for scans and treatments.

BioTech 107

BioTech Life Science Drug Development Patient Experience 107

Health Populi

JUNE 7, 2018

Some key findings from this study were that: The fastest-growing spending conditions between 2013 and 2014 were infectious disease, mental illness, and diabetes. The second chart indicates healthcare spending by category in billions of dollars and annual rate of growth.

Pharmaceuticals 206

Pharmaceuticals Public Health Mental health Health Policy 206

Health Populi

MAY 8, 2019

Total patient OOP costs in 2018 reached $61 billion, up $2 bn from 2017, and $5 bn from 2014. This takes us from the pharma manufacturer’s perspective to the patient’s role in the Rx ecosystem. Just under 9% of patients across all three health plan types had over $500 in OOP costs in 2018.

Medicare 149

Medicare BioTech Pharmaceuticals Mental health 149

Insulin Nation

MAY 3, 2016

In 2014, the pharmaceutical giant Sanofi agreed to market Afrezza, an inhalable insulin created by Mannkind Corporation. They include: -Mannkind officials blame the erosion of sales from uncertainty of supply after Sanofi’s unexpected cancellation of the 2014 marketing agreement. It didn’t work out that way. In the U.S.,

Pharmaceuticals 41

Pharmaceuticals Leadership 41

Insulin Nation

JANUARY 6, 2016

On January 5, news came that Sanofi and MannKind were severing ties on a licensing and marketing agreement the two companies reached for Afrezza in mid-2014, meaning that one of the biggest diabetes companies in the world was walking away from inhalable insulin. The post Sanofi Walks Away From Afrezza appeared first on Insulin Nation.

Pharmaceuticals 40

Pharmaceuticals 40

The Digital Health Corner

JANUARY 19, 2017

According to the National Institute on Drug Abuse (NIDA) from 2001 to 2014, deaths due to overdoses in the USA were noted as: 8 fold increase due to prescription drugs. There are medication assisted treatment (MATx) mobile apps to guide physicians in utilizing pharmaceutical drugs to treat addiction. 6 fold increase due to heroin.

Digital Health 60

Digital Health Health Technology Mental health Pharmaceuticals 60

Henry Kotula

JUNE 25, 2020

If spending continues to grow at the same rate that it has from 2014 to 2019, PwC forecasts a 6% medical cost trend. Specialty drug spending is also expected to drive up costs, as the majority of pharmaceuticals planned for release next year are specialty drugs.

Mental health 41

Mental health Telehealth Pharmaceuticals Telemedicine 41

Insulin Nation

JANUARY 6, 2016

On January 5, news came that Sanofi and MannKind were severing ties on a licensing and marketing agreement the two companies reached for Afrezza in mid-2014, meaning that one of the biggest diabetes companies in the world was walking away from inhalable insulin. Have Type 2 diabetes or know someone who does?

Pharmaceuticals 40

Pharmaceuticals 40

Insulin Nation

JANUARY 6, 2016

On January 5, news came that Sanofi and MannKind were severing ties on a licensing and marketing agreement the two companies reached for Afrezza in mid-2014, meaning that one of the biggest diabetes companies in the world was walking away from inhalable insulin. Have Type 2 diabetes or know someone who does?

Pharmaceuticals 40

Pharmaceuticals 40

American Well

FEBRUARY 8, 2016

pharmacies in 2014, 1 which has inevitably led pharmacists to focus more on volume and efficiency than on delivering personal care. In April 2014, the FSMB published a Model Policy for Telehealth that highlights the most critical factors for safe telehealth. In May 2014, the American Medical Association endorsed this policy.

Telehealth 54

Telehealth Pharmaceuticals Leadership Nursing 54

Insulin Nation

FEBRUARY 25, 2014

Insulin represents a golden goose for the pharmaceutical industry, especially as the number of people with Type 2 diabetes on insulin therapy increases. A 2011 insulin industry report predicted that the global insulin market will increase by 20% in 2014-2015. In January 2014, Sanofi sued Eli Lilly and Co.

Pharmaceuticals 111

Pharmaceuticals 111

Lloyd Price

FEBRUARY 13, 2024

The top three sectors for investment were: Digital health (£244 million) Therapeutics (£225 million) Medtech (£136 million) Some of the notable deals in 2022 included: Amphista Therapeutics (£38 million) Resolution Therapeutics (£34 million) ODx (£7.6

Healthcare Innovation 64

Healthcare Innovation Digital Health Life Science healthcare technology 64

Henry Kotula

JULY 1, 2019

Thirty-eight percent of large employers offered a worksite clinic in 2019, up from 27 percent in 2014. The trend has implications for employers, payers, providers and even pharmaceutical and life science companies. WHAT ELSE YOU SHOULD KNOW.

Life Science 32

Life Science Pharmaceuticals Mental health Telemedicine 32

Insulin Nation

OCTOBER 12, 2017

The SGLT2 drug canagliflozin (which goes by the brand name Invokana) had been linked to approximately 20 adverse event reports submitted to the FDA by the end of June 2014. In May 2015, The Institute for Safe Medication Practices published a brief article summarizing adverse events reported in 2014 from taking canagliflozin.

Pharmaceuticals 40

Pharmaceuticals 40

American Well

FEBRUARY 8, 2016

pharmacies in 2014, 1 which has inevitably led pharmacists to focus more on volume and efficiency than on delivering personal care. In April 2014, the FSMB published a Model Policy for Telehealth that highlights the most critical factors for safe telehealth. In May 2014, the American Medical Association endorsed this policy.

Telehealth 48

Telehealth Pharmaceuticals Leadership Nursing 48